AI-generated summary
The authors studied diphlorethohydroxycarmalol (DPHC), a natural compound, in human Müller glial cells and zebrafish exposed to blue light. They report that DPHC suppressed Müller gliosis, reduced retinal thinning and apoptosis, and inhibited CXCR4 activity, with in silico docking supporting CXCR4 as a target. The study used cell and animal models only, so the findings may not apply to humans.
- Who or what was studied
- MIO-M1 human Müller cells in vitro and zebrafish in vivo exposed to blue light
- Limits stated in the abstract
- Findings come from in silico, cell culture and zebrafish models only, with no human data reported in the abstract.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.